| 1 |
1nkemia IUCT Group SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 2 |
Ablynx NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 3 |
Acesis Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 4 |
Alopexx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 5 |
Alpine Immune Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 6 |
Ambrx Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 7 |
Amniotics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 8 |
Ampio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 9 |
Antibe Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 10 |
Apexigen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 11 |
Aptinyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 12 |
Aravive Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 13 |
Aridis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 14 |
Asarina Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 15 |
Aslan Pharmaceuticals Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 16 |
Axis-Shield Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 17 |
Baudax Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 18 |
Beijing Hongxianglong Biotechnolongy Co (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2013 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 19 |
Bellerophon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 20 |
Bellicum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 21 |
Better Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 22 |
Bio Synectics, Inc. (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 23 |
biOasis Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 24 |
Biotech-IgG Equity AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 25 |
Braster SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 26 |
C4X Discovery Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 27 |
Cannabis Global, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
5/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 28 |
Cannasouth Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 29 |
Cardax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 30 |
Ceapro Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 31 |
Cello Health Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 32 |
Cerevel Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 33 |
Chinook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 34 |
Cognetivity Neurosciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 35 |
CohBar Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 36 |
Comera Life Sciences Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 37 |
Crown LiquidationCo NV in liquidatie (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 38 |
Curative Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 39 |
CymaBay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 40 |
Darwin AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 41 |
Decibel Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 42 |
Destiny Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 43 |
Dice Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 44 |
eFFECTOR Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 45 |
Eiger Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 46 |
Eloxx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 47 |
Emplicure AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 48 |
Endonovo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 49 |
Enlighta Inc (British Virgin Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 50 |
Ergomed Group Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 51 |
Evelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 52 |
Evolutionary Genomics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 53 |
F3 Platform Biologics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 54 |
Fraunhofer-Gesellschaft zur Forderung der angewandten Forsch (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 55 |
Freeline Therapeutics Holdings PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 56 |
Fusion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 57 |
Gamida Cell Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 58 |
GeNeuro SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 59 |
Genomic Vision SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 60 |
Gracell Biotechnologies Inc (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 61 |
Green Scientific Labs Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 62 |
Gyroscope Therapeutics Holdings Ltd(ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 63 |
Harpoon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 64 |
HAVN Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 65 |
IBEX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 66 |
Icosavax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 67 |
Idogen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 68 |
Innoveren Scientific Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 69 |
ISR Immune System Regulation Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 70 |
IVERIC bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 71 |
Karuna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 72 |
Kazia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 73 |
Kinnate Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 74 |
Landos Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 75 |
Lexagene Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 76 |
LianBio - ADR (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 77 |
Liminal BioSciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 78 |
Lirum Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 79 |
Lophos Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 80 |
Luna Innovations Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 81 |
MagForce AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 82 |
Majestic Research Services & Sltns Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 83 |
Manuka Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 84 |
Mirati Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 85 |
Miromatrix Medical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 86 |
Myovant Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 87 |
Nabriva Therapeutics PLC - ADR (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 88 |
National Milk Records Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 89 |
Obseva SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 90 |
Ocean Biomedical Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 91 |
Old Ayala Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 92 |
Pardes Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 93 |
Phenomex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 94 |
Pherecydes Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 95 |
POINT Biopharma Global Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 96 |
Predictive Technology Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2021 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 97 |
Prometheus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 98 |
Psybio Therapeutics Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 99 |
R J Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 100 |
Rayont Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 101 |
RayzeBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 102 |
Regenicin Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 103 |
Regnum Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 104 |
ReNeuron Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 105 |
RoodMicrotec N.V. (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 106 |
Rubius Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 107 |
Science 37 Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 108 |
Scopus Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 109 |
Somalogic Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 110 |
Spexis AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 111 |
SQZ Biotechnologies Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 112 |
Statera Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 113 |
Surface Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 114 |
TCR2 Therapeutics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 115 |
THC Farmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 116 |
Theralink Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 117 |
Theseus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 118 |
Todos Medical Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 119 |
Trex Wind-Down Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 120 |
Tryp Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
2/29/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 121 |
Tuev Nord AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 122 |
Univo Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 123 |
US Stem Cell Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 124 |
Vaxxinity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 125 |
VBI Vaccines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2024 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 126 |
Vitaspring Biomedical Co. Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2022 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 127 |
Warrantee Inc (ADR) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 128 |
Wellfully Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
| 129 |
Zynerba Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2023 |
News |
SEC |
Bankruptcy |
Suits |
Liens |